Topic: Tekturna
ZURICH, Dec 20 - Swiss drugmaker Novartis said it was ending a study of a drug to treat high blood pressure after an independent body said it could increase risk to patients with a high risk of heart or kidney problems.Novartis said ...
LONDON (Reuters) - Patients with high blood pressure treated with a combination of a Novartis hypertension drug and a generic medicine do better than if they take only one of the drugs alone, trial data released on Thursday showed.The results of a ...
Tekturna (Aliskiren) is the first of a new drug class called Direct Renin Blockers.
Hypertension, also known as CBS News: | High Blood Pressure | Heart Disease | Kidney Disease | Chest Pain | ACE Inhibitor | Angiotensin II Receptor Blocker (ARB) | Beta Blocker | Calcium Channel Blocker | Tekturna (Aliskiren) | Altace (Ramipril) | ...
If you have any problems with your kidneys, have gout , or any cardiovascular problems, you may not be able to take Tekturna safely unless your doctor determines that this is okay by doing specific testing. You need to stick with healthy ...
The US Food and Drug Administration (FDA) approved Tekamlo (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine. "We welcome the ...
Results from 3A Registry demonstrate significant systolic blood pressure lowering with Rasilez after one year. ? After one year of treatment, Rasilez - the only approved direct renin inhibitor (DRI) - provided better systolic blood pressure control than other treatment regimens1. Results ...
ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worsening of its blood pumping ability, according to data ...
Updated European Society of Hypertension (ESH) guidelines recognize that Rasilez? monotherapy is effective at lowering blood pressure in a single daily dose1. The updated European Guidelines on Hypertension Management, appraised by an ESH task force, recognize that Rasilez effectively lowers high blood ...
The US Food and Drug Administration (FDA) has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood ...
